Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial
Published inOral oncology, vol. 82, p. 144-151
Publication date2018-07
Keywords
- Anti-EGFR
- Gene expression signatures
- Head and neck cancer
- Hypoxia signature
- Microenvironment score
- Progression-free survival
- Recurrent/metastatic
- Second line treatment
- MiRNA
Affiliation entities
Research groups
Citation (ISO format)
SIANO, Marco et al. Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial. In: Oral oncology, 2018, vol. 82, p. 144–151. doi: 10.1016/j.oraloncology.2018.05.013
Main files (1)
Article (Published version)
Identifiers
- PID : unige:175785
- DOI : 10.1016/j.oraloncology.2018.05.013
- PMID : 29909889
Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S1368837518301970
Journal ISSN1368-8375
